Aehr Test Systems (NASDAQ:AEHR) Shares Gap Up – Here’s Why

Aehr Test Systems (NASDAQ:AEHR) shares gapped up prior to trading on Friday . The stock had previously closed at $22.70, but opened at $23.90. Aehr Test Systems shares last traded at $23.7780, with a volume of 930,855 shares changing hands.

Trending Headlines about Aehr Test Systems

Here are the key news stories impacting Aehr Test Systems this week:

• Positive Sentiment: Management reinstated fiscal‑2026 guidance and set a revenue target of $25M–$30M, signaling improved visibility tied to AI‑driven demand; that lifted investor confidence. Aehr reinstates fiscal 2026 guidance
• Positive Sentiment: Aehr disclosed >$5.5M of Sonoma ultra‑high‑power system orders from leading AI and lab customers to test/burn‑in next‑gen CPUs/GPUs — concrete bookings that support the AI thesis. Aehr Announces Over $5.5M in Sonoma Orders
• Neutral Sentiment: Analyst and media takes are mixed — some note the company’s strong AI positioning and bookings potential, while others say management’s bigger forecasts need more proof from sustained revenue and order flow. Big Forecasts, More Proof Needed
• Negative Sentiment: Q2 revenue declined ~27% YoY to ~$9.9M and missed estimates; the company reported a loss per share and wider operating losses, driving near‑term concern about execution and profitability. Q2 Revenue Decline and EPS Miss
• Negative Sentiment: Cash flow is negative and the company showed modest cash burn with a smaller cash balance YoY; combined with several recent insider sales, this raises governance and financing questions for risk‑focused investors. Earnings and Insider Activity
• Neutral Sentiment: Company earnings call and multiple transcripts provide detail on product roadmap and customer discussions; these will be key to watch for concrete timing of large AI bookings converting to revenue. Q2 Earnings Call Transcript

Analysts Set New Price Targets

A number of equities analysts have recently issued reports on AEHR shares. Craig Hallum reissued a “hold” rating on shares of Aehr Test Systems in a research report on Friday. Zacks Research upgraded Aehr Test Systems from a “strong sell” rating to a “hold” rating in a report on Monday, December 8th. Weiss Ratings reissued a “sell (d)” rating on shares of Aehr Test Systems in a research note on Wednesday, October 8th. Finally, Lake Street Capital started coverage on Aehr Test Systems in a research report on Wednesday, December 17th. They set a “buy” rating on the stock. One research analyst has rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $21.00.

Aehr Test Systems Stock Up 15.9%

The firm has a 50 day moving average price of $22.75 and a 200 day moving average price of $22.61. The stock has a market capitalization of $789.86 million, a PE ratio of -87.73 and a beta of 2.33.

Aehr Test Systems (NASDAQ:AEHR) last announced its quarterly earnings results on Thursday, January 8th. The semiconductor company reported ($0.11) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.08) by ($0.03). Aehr Test Systems had a negative return on equity of 4.64% and a negative net margin of 16.63%.The company had revenue of $9.88 million for the quarter, compared to the consensus estimate of $11.45 million. On average, equities analysts forecast that Aehr Test Systems will post 0.1 earnings per share for the current fiscal year.

Insider Transactions at Aehr Test Systems

In other news, Director Howard T. Slayen sold 6,000 shares of the company’s stock in a transaction on Wednesday, November 5th. The shares were sold at an average price of $25.73, for a total value of $154,380.00. Following the completion of the sale, the director owned 218,328 shares in the company, valued at $5,617,579.44. This represents a 2.67% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. 6.80% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Aehr Test Systems

A number of institutional investors have recently added to or reduced their stakes in AEHR. Inspire Investing LLC boosted its position in Aehr Test Systems by 99.3% in the first quarter. Inspire Investing LLC now owns 48,148 shares of the semiconductor company’s stock worth $351,000 after purchasing an additional 23,990 shares during the last quarter. ARS Investment Partners LLC purchased a new stake in shares of Aehr Test Systems during the 2nd quarter valued at $300,000. Halter Ferguson Financial Inc. raised its stake in shares of Aehr Test Systems by 3.7% during the 2nd quarter. Halter Ferguson Financial Inc. now owns 439,714 shares of the semiconductor company’s stock worth $5,686,000 after purchasing an additional 15,541 shares during the period. Penbrook Management LLC boosted its holdings in shares of Aehr Test Systems by 205.1% in the 2nd quarter. Penbrook Management LLC now owns 126,250 shares of the semiconductor company’s stock worth $1,632,000 after buying an additional 84,875 shares during the last quarter. Finally, Bosun Asset Management LLC purchased a new position in shares of Aehr Test Systems in the 2nd quarter worth about $272,000. 69.69% of the stock is owned by institutional investors.

Aehr Test Systems Company Profile

Aehr Test Systems develops, manufactures and sells semiconductor test and burn-in equipment used by device manufacturers to ensure quality and reliability of integrated circuits. Its products are designed for wafer-level reliability assessment, functional test and stress screening of memory devices, system-on-chips, optical components and power semiconductors. By focusing on wafer-level burn-in and testing processes, the company helps reduce cost and improve yield for high-volume semiconductor production.

The company’s product portfolio includes FOX series wafer probe test and burn-in systems as well as ABTS burn-in ovens.